Article Information
History
- January 18, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Raj Kalkeri, Ph.D.1,*,
- Mingzhu Zhu, Ph.D.1,
- Shane Cloney-Clark, B.Sc.1,
- Joyce S. Plested, Ph.D.1,
- Anand Parekh, M.Sc.1,
- Drew Gorinson, B.S.1,
- Rongman Cai, Ph.D.1,
- Soham Mahato, Ph.D.1,
- Pradhipa Ramanathan, M.Sc.2,
- L. Carissa Aurelia, B.Sc.2,
- Kevin John Selva, Ph.D.2,
- Anthony M. Marchese, Ph.D.1,
- Louis Fries, M.D.1,
- Amy W. Chung, Ph.D.2 and
- Lisa M. Dunkle, M.D.1
- 1Novavax, Inc., Gaithersburg, MD, USA
- 2Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Victoria, 3000, Australia
- ↵*Corresponding author: Raj Kalkeri, RKalkeri{at}Novavax.com
Posted January 18, 2024.
